Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2003
08/06/2003CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives
08/06/2003CN1434825A Novel imidazo ÒÇö1,3,5ÒÇòtriazinones and the use thereof
08/06/2003CN1434771A Optical recording medium and novel azaporphyrin compounds
08/06/2003CN1434049A Improved method for preparing crosslinke endomarcocyclic compound
08/06/2003CN1434045A Process for preparing optical active ketorolac
08/06/2003CN1117094C Processfor preparing 5H, 96H-2a, 4a, 7,9a-actahydrotetraaze-cycloocta (cd) pentalene
08/06/2003CN1117093C Pyrazolo [1,5-a] pyrimidine derivatives, its use and composition
08/05/2003US6603070 Convergent method for the synthesis of light harvesting rods. The rods are oligomers of the formula A1(Ab+1)b, wherein b is at least 1, A1 through Ab+1 are covalently coupled rod segments, and each rod segment A1 through A1+b comprises a
08/05/2003US6603020 Fluorescent diketopyrrolopyrroles
08/05/2003US6603002 Process and intermediates for growth hormone secretagogues
08/05/2003US6602998 Mercapto-substituted imidazolylporphyrin metal complex monomer, polymer having the same as a repeating unit and method of preparing the same
08/05/2003US6602879 Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
08/05/2003US6602875 Sorbitol dehydrogenase inhibitors
08/05/2003US6602863 Irreversible inhibitors of tyrosine kinases
08/05/2003US6602826 Heterocyclically substituted aromatic amino compounds with a herbicidal effect
08/05/2003US6602366 Metal complexes; for smokeless fireworks
08/05/2003CA2082934C Phthalocyanatopolyethylene glycol, and phthalocyanato saccharides as fluorescent digoxin reagents
08/01/2003CA2418410A1 Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
07/2003
07/31/2003WO2003062323A1 Water-soluble phthalocyanine compound-containing ink for ink jetting, ink jet recording method and method for improving ozone gas discoloration of colored image material
07/31/2003WO2003062241A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
07/31/2003WO2003062238A1 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors
07/31/2003WO2003061803A1 Extraction method
07/31/2003WO2003061604A2 Novel alkyl/aryl hydroxy or keto thiepines.
07/31/2003WO2003061388A1 Fused heterocyclic sulfonylurea compound, herbicide containing the same, and method of controlling weed with the same
07/31/2003WO2003039460A3 Mitotic kinesin inhibitors
07/31/2003WO2003032911A3 Anti-angiogenic and cytotoxic fused pyrimidines
07/31/2003WO2002092065A3 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
07/31/2003WO2002068421A3 Tricyclic compounds and their analogs as inhibitors of cytokine signaling
07/31/2003US20030144562 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene
07/31/2003US20030144530 Novel process for the preparation of pyrazoles
07/31/2003US20030144509 Prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in immunocompromised patients.
07/31/2003US20030144504 Dialkyl-halogenophenyl-substituted ketoenols
07/31/2003US20030144305 Novel compounds
07/31/2003US20030144294 Antiproliferative or anticarcinogenic agents comprising reaction products of ninhydrin or benzo(f)ninhydrin with 1,5-diaminotetrazole; enzyme inhibitors
07/31/2003US20030144282 Inhibitors of cytosolic phospholipase A2
07/31/2003US20030144266 Pyrazolo-triazolo- pyrimidine, triazolo-triazolo-pyrimidine and imidazolo-triazolo-pyrimidine derivatives useful for the treatment of hypertension, inflammation, mast cell degranulation, cardiac hypoxia, and ischemia
07/31/2003US20030144264 Carbapenems containing a carboxy substituted phenyl group and useful for treating bacterial infections in mammals and humans
07/31/2003US20030144263 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
07/31/2003US20030144234 Administering a cathepsin modulator or enzyme inhibitor, select from a mRNA or a protein; gene expression inhibition, analgesics
07/31/2003US20030143481 Image forming material and ammonium compound
07/31/2003US20030140820 Pigmented vitreous material
07/31/2003US20030140787 Cucurbiturils and method for binding gases and volatiles using cucurbiturils
07/31/2003CA2473420A1 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors
07/31/2003CA2471639A1 Novel alkyl/aryl hydroxy or keto thiepines.
07/31/2003CA2471342A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
07/30/2003EP1331225A1 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides
07/30/2003EP1330458A1 N-( 1,2,4]triazoloazinyl) thiophenesulfonamide compounds as herbicides
07/30/2003EP1330457A2 Cyclopenta[b][1,4] diazepino[6,7,1-hi]indoles as 5ht2c antagonists
07/30/2003EP1330443A1 Substituted phenyluracils
07/30/2003CN1433417A Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
07/30/2003CN1433411A Chemical compounds
07/30/2003CN1433402A Cycloamine CCR5 receptor antagonists
07/30/2003CN1433312A Barbituric acid analogs as therapeutic agents
07/29/2003US6600043 Carboxylic acid derivatives, their preparation and use
07/29/2003US6600042 Preparation of pyrimido(5,4-g)pteridine of formula I reacting the pyrimidine of formula II with the pyrimidine of formula III in the presence of an acid and, if desired, of a solvent, the molar ratio of the acid to the compound of formula II
07/29/2003US6600041 Cyclization of an aminopyrrole compound
07/29/2003US6600038 Carbamoyl tetrahydropyridine derivatives
07/29/2003US6600036 Treating diseases of the central nervous system.
07/29/2003US6599511 Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence
07/29/2003CA2262268C Method of treating impotence due to spinal cord injury
07/29/2003CA2244621C 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor antagonists
07/24/2003WO2003060085A2 Mammalian neural stem cells, compositions and uses thereof
07/24/2003WO2003060082A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
07/24/2003WO2003059909A1 A process for producing phenserine and its analog
07/24/2003WO2003059889A1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
07/24/2003WO2003059353A1 Tyrosyl derivatives and their use as p2x7 receptor modulators
07/24/2003WO2003059276A2 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
07/24/2003WO2003059269A2 Acridone inhibitors of impdh enzyme
07/24/2003US20030139598 Process for the preparation of triethylenediamine (TEDA)
07/24/2003US20030139462 Antiinflammatory agents; autoimmune disease; antiarthritic agents
07/24/2003US20030139427 Sedatives; vasodilation; antiinflammatory agents; cardiovascular disorders
07/24/2003US20030139426 Pyrazolopyrimidines as CRF antagonists
07/24/2003US20030139415 Novel heterocycles 3
07/24/2003US20030139410 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
07/24/2003US20030139397 Pesticides
07/24/2003US20030139394 Dibenzodiazepine derivatives, their preparation and use
07/24/2003US20030139393 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
07/24/2003US20030136964 Thin film transistors using solution processed pentacene precursor as organic semiconductor
07/24/2003CA2700690A1 Process for producing reformatsky reagent in stable form
07/24/2003CA2474141A1 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
07/24/2003CA2471562A1 Tyrosyl derivatives and their use as p2x7 receptor modulators
07/23/2003EP1329493A2 Electroluminescent devices comprising diketopyrrolopyrroles
07/23/2003EP1329450A1 Benzodiazepine derivative
07/23/2003EP1328527A1 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents
07/23/2003EP1328526A1 3,8-diazabicyclo[3.2.1]octanes and their use in the treatment of cardiac arrhythmias
07/23/2003EP1328525A2 2,3,4,5-tetrahydro-1h-[1,4]diazepino[1,7-a]indole compounds
07/23/2003EP1328514A1 Amide derivatives as nmda receptor antagonists
07/23/2003EP1129093B1 Pyrazolopyrimidinone derivatives for the treatment of impotence
07/23/2003EP1032575B1 2,3-diaryl-pyrazolo(1,5-b)pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
07/23/2003EP1015452B1 Optionally protected 3-hydroxymethyl carbapenems and synthesis
07/23/2003EP0983274B1 Phthalocyanine and use of phthalocyanine as a marking agent
07/23/2003EP0975636B1 1h-pyrazolo[3,4-d]pyrimidine-4,6-diones as t-cell proliferation inhibitors
07/23/2003EP0929528B1 Aralkyl and aralkylidene heterocyclic lactams and imides
07/23/2003CN1432019A Hygromycin derivatives for treatment of bacterial and protozoal infections
07/23/2003CN1432018A Crystalline and amorphous form of triazolo (4,5-d) pyrimidine compound
07/23/2003CN1432017A Triazolo pyrimidine compounds
07/23/2003CN1432000A TNF-alpha prodn. inhibitors
07/23/2003CN1431992A Process for prepn. of cyclopropyl carboxylic acid esters and derivatives
07/23/2003CN1431915A Treatment of congestive heart failure with compsn. comprising diuretic agent and vasopressin antagonist
07/23/2003CN1115341C Substituted N-methyl-N-(4-(1H-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases